1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
2 votes

Topics under Therapy

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 28000 reports

Global Therapy and Anti-Infective Market

  • March 2017
    6 pages
  • Therapy  

    Anti-Infective  

  • World  

View report >

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Therapy Market in Europe

  • January 2017
    21 pages
  • Europe  

View report >

Endocrine Disease Statistics and Therapy Market in Europe and Asia

  • December 2016
    83 pages
  • Endocrine Disea...  

    Therapy  

    Lung Cancer  

  • Europe  

    Asia  

View report >

Therapy Market in Japan and the US - Forecast

  • March 2017
    9 pages
  • Therapy  

  • Japan  

    United States  

View report >

Therapy Market in France

  • November 2016
    7 pages
  • Therapy  

  • France  

    Europe  

View report >

Anti-Infective and Therapy Market in Germany

  • March 2017
    11 pages
  • Anti-Infective  

    Therapy  

    Asthma  

  • Germany  

View report >

Glucagon Like Peptide 1 Receptor Activator and Therapy Market in Italy

  • November 2016
    11 pages
  • Glucagon Like P...  

    Therapy  

    Antidiabetics  

  • Italy  

View report >

Hepatitis Statistics and Therapy Market in the UK

  • March 2017
    10 pages
  • Hepatitis  

    Therapy  

    Antiviral  

  • United Kingdom  

View report >

Therapy Market and Lung Cancer Statistics in Canada - Forecast

  • March 2017
    64 pages
  • Therapy  

    Lung Cancer  

    Targeted Therap...  

  • Canada  

View report >


About 8200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 175 - $ 75000)

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Eu ...

January 2017 $ 52400

2017 World Tumor Marker Diagnostics Market: North Ameri ...

January 2017 $ 52400

2017 Europe Immunodiagnostics Market: Over 100 Special ...

February 2017 $ 37500

2017 Europe Clinical Chemistry Market: Over 100 Special ...

February 2017 $ 37500

2017 Europe Tumor Marker Diagnostics Market: Sales Fore ...

February 2017 $ 36000

2017 World Clinical Chemistry And Immunodiagnostics Mar ...

March 2017 $ 23500

2017 Global Clinical Chemistry And Immunodiagnostics Ma ...

March 2017 $ 23500

2017-2021 World Clinical Chemistry And Immunodiagnostic ...

February 2017 $ 23500

2017 World Cancer Diagnostics Market Future Horizons An ...

March 2017 $ 21100

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.